Literature DB >> 8499404

Increased production rates of LDL are common in individuals with low plasma levels of HDL cholesterol, independent of plasma triglyceride concentrations.

H N Ginsberg1, C Ngai, X J Wang, R Ramakrishnan.   

Abstract

Reduced plasma levels of high density lipoprotein (HDL) cholesterol are associated with increased risk for coronary heart disease. Although plasma HDL levels are, in general, inversely related to plasma triglyceride (TG) concentrations, a small proportion of individuals with low HDL cholesterol concentrations have normal plasma TG levels. We wished to determine whether subjects with low plasma levels of HDL cholesterol could be characterized by common abnormalities of lipoprotein metabolism independent of plasma TGs. Therefore, we studied the metabolism of low density lipoprotein (LDL) apolipoprotein B (apo B) and HDL apolipoprotein A-I (apo A-I) in subjects with low plasma HDL cholesterol concentrations with or without hypertriglyceridemia. Nine subjects with low plasma HDL cholesterol levels and normal levels of plasma TGs and LDL cholesterol were studied. Autologous 131I-LDL and 125I-HDL were injected intravenously, and blood samples were collected for 2 weeks. LDL apo B and HDL apo A-I levels were measured by specific radioimmunoassays. Fractional catabolic rates (FCRs, pools per day) and production rates (PRs, milligrams/kilogram.day) for each apolipoprotein were determined. The results were compared with those obtained previously in nine subjects with low plasma HDL cholesterol levels and hypertriglyceridemia and in seven normal subjects. The normal subjects had an HDL apo A-I FCR (mean +/- SD) of 0.21 +/- 0.04. Despite large differences in plasma TG levels, the HDL apo A-I FCRs were similar in the low-HDL, normal-TG group (0.30 +/- 0.09) and the low-HDL, high-TG group (0.33 +/- 0.10), although only the latter value was significantly increased versus control subjects (p < 0.03). Increased apo A-I FCRs were associated with reduced HDL apo A-I levels in both groups of patients. Apo A-I PRs were similar in all groups. In contrast, LDL apo B PR was increased approximately 50% in the low-HDL, normal-TG group (19.3 +/- 6.6; p < 0.01) compared with normal subjects (12.5 +/- 2.6). There was a strong trend toward a greater LDL apo B PR in the low-HDL, high-TG group (17.6 +/- 4.5; p = 0.06 versus normal subjects) as well. LDL apo B FCRs were similar in all three groups. LDL apo B concentrations were also increased in the group with low HDL cholesterol and normal TG levels. Both groups with low HDL cholesterol levels had cholesterol-depleted LDL and HDL particles.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8499404      PMCID: PMC3277740          DOI: 10.1161/01.atv.13.6.842

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  56 in total

1.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

Authors:  M A Austin; M C King; K M Vranizan; R M Krauss
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

2.  Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.

Authors:  I J Goldberg; W S Blaner; T M Vanni; M Moukides; R Ramakrishnan
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

3.  Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.

Authors:  Y Arad; R Ramakrishnan; H N Ginsberg
Journal:  J Lipid Res       Date:  1990-04       Impact factor: 5.922

4.  Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia.

Authors:  C J Mann; F T Yen; A M Grant; B E Bihain
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

5.  Dissociation of apoprotein B and triglyceride production in very-low-density lipoproteins.

Authors:  J Melish; N A Le; H Ginsberg; D Steinberg; W V Brown
Journal:  Am J Physiol       Date:  1980-11

6.  Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia.

Authors:  E A Brinton; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

7.  Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids.

Authors:  H Gylling; G L Vega; S M Grundy
Journal:  J Lipid Res       Date:  1992-10       Impact factor: 5.922

8.  Enrichment of endothelial cell arachidonate by lipid transfer from high density lipoproteins: relationship to prostaglandin I2 synthesis.

Authors:  K B Pomerantz; L N Fleisher; A R Tall; P J Cannon
Journal:  J Lipid Res       Date:  1985-10       Impact factor: 5.922

9.  HDL2 and HDL3 lipid levels in coronary artery disease.

Authors:  L Wallentin; B Sundin
Journal:  Atherosclerosis       Date:  1986-02       Impact factor: 5.162

10.  Turnover of apoproteins A-I and A-II of high density lipoprotein and the relationship to other lipoproteins in normal and hyperlipidemic individuals.

Authors:  N Fidge; P Nestel; T Ishikawa; M Reardon; T Billington
Journal:  Metabolism       Date:  1980-07       Impact factor: 8.694

View more
  2 in total

Review 1.  Insulin: a novel agent in the pathogenesis of prostate cancer.

Authors:  Hanumanthappa Nandeesha
Journal:  Int Urol Nephrol       Date:  2008-07-30       Impact factor: 2.370

2.  Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM.

Authors:  C M Forsblom; J G Eriksson; A V Ekstrand; A M Teppo; M R Taskinen; L C Groop
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.